bismuth has been researched along with Colonic Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral-Romero, C; Chellam, S; García-Cuéllar, CM; Hernandez-Delgadillo, R; Meester, I; Nakagoshi-Cepeda, MAA; Nakagoshi-Cepeda, SE; Pérez-Carrillo, E; Pineda-Aguilar, N; Sánchez-Nájera, RI; Sánchez-Pérez, Y; Solís-Soto, JM | 1 |
| Andrews, PC; Dillon, CT; Hawksworth, EL; Lai, B; Lie, W | 1 |
| Imura, N; Naganuma, A; Satoh, M | 2 |
| Albert, P; Brechbiel, M; Chappell, L; Dadachova, E; Garmestani, K; Hill, D; Milenic, D; Schlom, J | 1 |
| de Vos, D; Ho, PC; Lai, CS; Li, H; Tiekink, ER; Wu, J | 1 |
| Chee, YC | 1 |
| Apostolidis, C; Becker, W; Béhé, M; Behr, TM; Fayyazi, A; Goldenberg, DM; Gratz, S; Koch, L; Molinet, R; Stabin, MG; Strutz, F; Wehrmann, E; Wieland, E | 1 |
| Alvarez, VL; Hauler, JA; Simonson, RB; Ultee, ME | 1 |
| Atcher, RW; Brechbiel, MW; Hines, JJ; Langmuir, VK | 1 |
| Imura, N; Kawamura, E; Matsuzaki, N; Miura, N; Naganuma, A; Satoh, M | 1 |
| Imura, N; Koyama, Y; Naganuma, A; Satoh, M | 1 |
| Barron, VJ; Burns, R; Thomas, DW | 1 |
13 other study(ies) available for bismuth and Colonic Neoplasms
| Article | Year |
|---|---|
Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
Topics: Animals; Antineoplastic Agents; Bismuth; Cell Line, Tumor; Colonic Neoplasms; Female; HeLa Cells; Humans; Hydrogels; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Prostatic Neoplasms; Uterine Cervical Neoplasms | 2020 |
Biological evaluation of bismuth non-steroidal anti-inflammatory drugs (BiNSAIDs): stability, toxicity and uptake in HCT-8 colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Coordination Complexes; Diflunisal; Drug Evaluation, Preclinical; Drug Stability; Humans; Inhibitory Concentration 50; Mefenamic Acid; ortho-Aminobenzoates | 2014 |
Modulation of adriamycin toxicity by tissue-specific induction of metallothionein synthesis in mice.
Topics: Animals; Antibiotics, Antineoplastic; Bismuth; Bone Marrow Diseases; Colonic Neoplasms; Copper; Doxorubicin; Leukocyte Count; Male; Metallothionein; Metals; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tissue Distribution; Zinc | 2000 |
Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Colonic Neoplasms; Humans; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Radioimmunotherapy; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays | 2004 |
Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.
Topics: Animals; Bismuth; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; HT29 Cells; Humans; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organometallic Compounds; Ovarian Neoplasms; Quantitative Structure-Activity Relationship; Random Allocation; Spectrophotometry, Infrared; Thiocarbamates; Xenograft Model Antitumor Assays | 2007 |
An unusual radiographic presentation of colonic carcinoma after medication for peptic ulcer.
Topics: Adenocarcinoma; Aged; Bismuth; Colonic Neoplasms; Female; Humans; Peptic Ulcer; Radiography | 1980 |
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Bone and Bones; Colonic Neoplasms; Female; Half-Life; Humans; Immunoglobulin Fab Fragments; Kidney; Linear Energy Transfer; Mice; Mice, Nude; Radioimmunotherapy; Radioisotopes; Relative Biological Effectiveness; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 1999 |
Radioimmunotherapy of peritoneal human colon cancer xenografts with site-specifically modified 212Bi-labeled antibody.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Colonic Neoplasms; Humans; Mice; Neoplasm Transplantation; Peritoneal Neoplasms; Radioisotopes; Survival Rate; Transplantation, Heterologous | 1990 |
Iodine-125-NRLU-10 kinetic studies and bismuth-212-NRLU-10 toxicity in LS174T multicell spheroids.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bismuth; Cell Line; Colonic Neoplasms; Humans; In Vitro Techniques; Iodine Radioisotopes; Radioisotopes; Tumor Cells, Cultured | 1990 |
Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice.
Topics: Adenocarcinoma; Animals; Bismuth; Bone Marrow; Colonic Neoplasms; Gamma Rays; Leukemia P388; Male; Metallothionein; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Radiation, Ionizing | 1989 |
Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
Topics: Adenocarcinoma; Animals; Bismuth; Cisplatin; Colonic Neoplasms; Kidney; Kidney Diseases; Metallothionein; Mice; Neoplasm Transplantation | 1987 |
Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bismuth; Carcinoma, Ehrlich Tumor; Cisplatin; Colonic Neoplasms; Doxorubicin; Heart; Kidney; Male; Metallothionein; Mice; Mice, Inbred ICR | 1988 |
Reversible encephalopathy possibly associated with bismuth subgallate ingestion.
Topics: Adult; Aged; Alanine; Arginine; Bismuth; Brain Diseases; Cerebellum; Chromatography; Cognition Disorders; Colonic Neoplasms; Colostomy; Female; Hallucinations; Humans; Libido; Male; Middle Aged; Myoclonus; Purkinje Cells; Tremor | 1974 |